A New Challenge for Global Companies: Successfully Managing MLO and NGO Relationships

A telltale sign of the growing importance of multilateral organizations (MLOs) and nongovernmental organizations (NGOs) to companies today is the increased human resources dedicated to managing relationships with them. Multinational companies today are investing the time and talent to ensure that their relationships with MLOs and NGOs are active and positive. Although the field is awash in articles about the importance of MLOs and NGOs to companies, remarkably little is documented about how companies can best engage these multilateral and nonprofit actor

Ahead of the Curve: Insights for the International NGO of the Future

International NGOs have a unique and important role to play in addressing today's complex global challenges. But few of them are living up to their full potential. With support from the Hewlett Foundation, FSG researched how the most innovative INGOs are adapting to the disruptions in the global development sector and embracing four approaches to create greater impact

Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health

This report looks at how pharmaceutical and medical device companies can create shared value in global health by addressing unmet health needs in low- and middle-income countries. Companies have already begun to reap business value and are securing competitive advantages in the markets of tomorrow

Smarter Programming of the Female Condom: Increasing Its Impact on HIV Prevention in the Developing World

The purpose of this study was to investigate the relative value of the female condom for HIV prevention within heterosexual relationships in the developing world. In the last ten years, the world has witnessed both historic financial commitments to HIV/AIDS and new prevention options, including biomedical prevention research, male circumcision, and a dramatic scale-up of voluntary counseling and testing. At the same time, where HIV remains at epidemic levels in many countries, there has been a growing commitment to treatment access alongside prevention programs. However, portions of populations, particularly youth and women, remain highly vulnerable to HIV infection. Accordingly, the global health community can benefit from a better understanding of how existing prevention options should be effectively and efficiently delivered to reduce HIV in the developing world. This report provides guidance for the global health community for considering how the female condom fits within the set of prevention interventions currently available